# Daiki Iguchi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daiki-iguchi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 189 |
| Field | Dialysis and Renal Disease Management |
| h-index | 7 |
| i10-index | 7 |
| Last Known Institution | Japanese Red Cross Nagoya Daini Hospital |
| OpenAlex ID | https://openalex.org/A5068768695 |
| Works | 20 |

## Researcher papers

- [Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients](https://scholariq.org/papers/quality-of-life-and-emotional-distress-in-peritoneal-dialysis-and-hemodialysis/)
- [Liraglutide relieves cardiac dilated function than <scp>DPP</scp>‐4 inhibitors](https://scholariq.org/papers/liraglutide-relieves-cardiac-dilated-function-than-scp-dpp-scp-4-inhibitors/)
- [Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury](https://scholariq.org/papers/vascular-endothelial-growth-factor-receptor-3-is-a-novel-target-to-improve-net/)
- [High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients](https://scholariq.org/papers/high-levels-of-soluble-c5b-9-complex-in-dialysis-fluid-may-predict-poor/)
- [Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy](https://scholariq.org/papers/expression-of-membrane-complement-regulators-cd46-cd55-and-cd59-in-mesothelial/)
- [Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment](https://scholariq.org/papers/impact-of-glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose/)
- [Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal](https://scholariq.org/papers/anti-c5a-complementary-peptide-mitigates-zymosan-induced-severe-peritonitis-with/)
- [C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis](https://scholariq.org/papers/c1-inhibitor-mitigates-peritoneal-injury-in-zymosan-induced-peritonitis/)
- [Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term Remission](https://scholariq.org/papers/light-chain-deposition-disease-recurrence-in-renal-allograft-after-long-term/)
- [Higher dental care is positively associated with key prognosis factors in peritoneal dialysis patients: findings from a retrospective study](https://scholariq.org/papers/higher-dental-care-is-positively-associated-with-key-prognosis-factors-in/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Japanese Red Cross Nagoya Daini Hospital](https://scholariq.org/institutions/japanese-red-cross-nagoya-daini-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.